More Globe Newswire

View Older Stories View Newer Stories

Mar 17, 2026 08:00AM TFTIOR Expands Importer of Record Operations for Data Center and Telecom Infrastructure Deployments
Mar 17, 2026 07:59AM Mythic® Selects memBrain™ Technology from Silicon Storage Technology® for its Next Generation of Ultra-Low-Power Analog Processing Units
Mar 17, 2026 07:50AM Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Mar 17, 2026 07:50AM HCW Biologics Closes Exclusive Worldwide License for HCW11-006 – A High Potential Fusion Immunotherapeutic
Mar 17, 2026 07:50AM HCW Biologics Closes Exclusive Worldwide License for HCW11-006 – A High Potential Fusion Immunotherapeutic
Mar 17, 2026 07:47AM Can-Fite Expands Namodenoson anti-Obesity Franchise with Israeli Patent Allowance
Mar 17, 2026 07:45AM Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer
Mar 17, 2026 07:45AM Cycurion, Inc. Statement Regarding Unauthorized Press Release, Fabrication of Investor Relations Contact, and Related Market Activity – Litigation Counsel Engaged to Address Short Selling and Manipu
Mar 17, 2026 07:44AM Fusemachines to Participate in the 38th Annual ROTH Conference
Mar 17, 2026 07:43AM Neuroscale AI Secures $540,000 DoD SBIR Phase II (D2P2) Award to Advance Secure Multimodal AI for Federal Decision-Making
Mar 17, 2026 07:39AM Form 8.3 - Picton Property Income Limited
Mar 17, 2026 07:38AM Form 8.3 - Life Science REIT Plc
Mar 17, 2026 07:37AM Organoid COMMONS Announces Formation of Governing Board, Appointment of Alliance Director, and Announces Open Call for New COMMONS Members
Mar 17, 2026 07:37AM Form 8.3 - LondonMetric Property Plc
Mar 17, 2026 07:35AM Form 8.3 - British Land Co plc
Mar 17, 2026 07:34AM Form 8.3 - Bluefield Solar Income Fund Ltd
Mar 17, 2026 07:30AM Knight Therapeutics Announces Approval of Additional Indication for MINJUVI® (tafasitamab) in Brazil
Mar 17, 2026 07:30AM Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI® (tafasitamab) for Follicular Lymphoma in Argentina and Mexico
Mar 17, 2026 07:30AM POET Technologies and Lessengers Expand Partnership to Deliver 1.6T 2×DR4 Optical Transceivers for AI Network Connectivity
Mar 17, 2026 07:30AM Cognition Therapeutics Presents Evidence of Zervimesine’s Impact on Neuropsychiatric Symptoms of Dementia with Lewy Bodies at AD/PD 2026
Mar 17, 2026 07:30AM Xtract One Chosen by Morgan County Schools for Amplified Security at District’s High School Campuses
Mar 17, 2026 07:30AM SL Green Realty Corp. to Release First Quarter 2026 Financial Results after Market Close on April 15, 2026
Mar 17, 2026 07:30AM Xsolla SPAC 1 Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing March 18, 2026
Mar 17, 2026 07:30AM CervoMed Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates
Mar 17, 2026 07:30AM MiNK Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Highlight Platform Expansion Across iNKT Cell Therapy Programs
Mar 17, 2026 07:30AM Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference
Mar 17, 2026 07:30AM Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates
Mar 17, 2026 07:30AM Terrestrial Energy Announces Fourth Quarter and Full Year 2025 Earnings Release and Conference Call Date
Mar 17, 2026 07:30AM Rekor Systems to Announce 2025 Results
Mar 17, 2026 07:25AM Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms
Mar 17, 2026 07:21AM PaymentWorks Customers Now Qualify for Up to $5 Million in Total Fraud Coverage
Mar 17, 2026 07:20AM ProVen Growth and Income VCT plc: Issue of Equity
Mar 17, 2026 07:15AM X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Mar 17, 2026 07:11AM Introducing Prodigy Math Facts: A Fun New Way to Build Student Math Fluency
Mar 17, 2026 07:10AM Man Group PLC : Form 8.3 - LondonMetric Property Plc
Mar 17, 2026 07:10AM TryHard Holdings Limited Announces: Receipt of Nasdaq Notification Regarding Minimum Price Deficiency, and Termination of Standby Equity Purchase Agreement With Summer Explorer
Mar 17, 2026 07:09AM ProVen VCT plc: Issue of Equity
Mar 17, 2026 07:09AM
Mar 17, 2026 07:05AM EV Cargo Sharpens Strategic Focus on Global Forwarding
Mar 17, 2026 07:05AM Bitfarms Schedules Fourth Quarter 2025 Conference Call on March 31, 2026
Mar 17, 2026 07:03AM Clarios Connected Services introduces Battery Manager Pro at TMC 2026
Mar 17, 2026 07:00AM Ms. Chafika Eddine joins Xali Gold Board of Directors
Mar 17, 2026 07:00AM Vior Gold Corporation Intersects High-Grade Mineralization at Ligneris
Mar 17, 2026 07:00AM Monte Rosa Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates
Mar 17, 2026 07:00AM Verde Expands Minas Americas Magnet-Rich Ionic Clay Discovery Beyond 3.5 km²; MAV_AD_0028 Returns 10 m at 0.84% TREO
Mar 17, 2026 07:00AM Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics
Mar 17, 2026 07:00AM Two-Thirds of Canadians (67%) Say it’s Time to Abolish Tips, Reveals New H&R Block Canada Study
Mar 17, 2026 07:00AM Goodfood Appoints Najib Maalouf as President and Chief Operating Officer
Mar 17, 2026 07:00AM R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease
Mar 17, 2026 07:00AM Guardian Capital Announces March 2026 Cash Distributions for Guardian Capital ETFs
View Newer Stories View Older Stories